Drug Delivery - Drug Programs Part 2 Tender in Poland - 139860106

Procurement Summary

Country: Poland

Summary: Drug Delivery - Drug Programs Part 2

Deadline: 21 May 2026

Posting Date: 21 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 139860106

Document Ref. No.: 269989-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: PLN 249747

CPV Classification

33600000 - Pharmaceutical products
33692000 - Medical solutions
33670000 - Medicinal products for the respiratory system

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

TASK NO. 1 - nivolumab drug program TASK NO. 2 - ipilimumab-drug program TASK NO. 3 - atezolizumab - drug program TASK NO. 4 - pembrolizumab drug program TASK NO. 5 - durvalumab drug program TASK NO. 6 -MEPOLIZUMAB drug program treatment of severe IgE-dependent allergic asthma and severe eosinophilic asthma TASK NO. 7 OMALIZUMAB drug program for the treatment of severe IgE-dependent allergic asthma The subject of the order is the successive delivery of medicines, including drug programs, to hospital pharmacy - in accordance with the name and quantity specified in the pricing tasks. The subject of the order was divided into tasks. The Ordering Party allows the submission of partial offers in accordance with the following description: Task No. 1 - nivolumab - the drug program should offer apply to the entire task; Task No. 2 - ipilimumab - drug program - the offer should cover the entire task; Task No. 3 - atezolizumab - drug program - the offer should cover the entire task; Task No. 4 - pembrolizumab drug program - the offer should apply to the entire task; Task No. 5 - durvalumabum drug program - the offer should cover the entire task; Task No. 6 - MEPOLIZUMAB drug program for the treatment of severe IgE-dependent allergic asthma and severe eosinophilic asthma - the offer should concern the entire task; Task No. 7 - OMALIZUMAB drug program for the treatment of severe IgE-dependent allergic asthma - the offer should cover the entire task without being broken down into individual items; Nivolumabum 10mg/...
Document Type: Contract Notice Reference Number: ZP/04/2026 Contract Type: supplies Estimated Value: 249747 - PLN Authority Type: body-pl Doc Title: Dostawa leków - programy lekowe cz. 2 Dispatch Date: 2026-04-20 Publish Date: 2026-04-21 Submission Date: 2026-05-21

Documents

 Tender Notice